Skip to content
10-Q

Quarterly Report

SCOPUS BIOPHARMA INC.

0001410578-23-001787

← back to feed
Filed
Aug 11, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 11, 2023 42.08M sh
Shares Diluted Q2 2023 · Jun 30, 2023 39.74M sh
Shares Diluted Q2 2023 · Jun 30, 2023 35.08M sh
Shares Diluted Q2 2023 · Jun 30, 2022 21.09M sh
Shares Diluted Q2 2023 · Jun 30, 2022 21.09M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$1.77M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$6.85M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $362.1K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $124.58K
Stockholders Equity Q2 2023 · Jun 30, 2023 −$9.45M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$6.56M
Current Liabilities Q2 2023 · Jun 30, 2023 $11M
Current Liabilities Q2 2023 · Dec 31, 2022 $7.45M
Current Assets Q2 2023 · Jun 30, 2023 $495.85K
Current Assets Q2 2023 · Dec 31, 2022 $390K
Total Assets Q2 2023 · Jun 30, 2023 $497.55K
Total Assets Q2 2023 · Dec 31, 2022 $392.27K
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.07
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.14
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.16
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.38
Eps Basic Q2 2023 · Jun 30, 2023 −$0.07
Eps Basic Q2 2023 · Jun 30, 2023 −$0.14
Eps Basic Q2 2023 · Jun 30, 2022 −$0.16
Eps Basic Q2 2023 · Jun 30, 2022 −$0.38
Sga Expense Q2 2023 · Jun 30, 2023 $935.86K
Sga Expense Q2 2023 · Jun 30, 2023 $2.01M
Sga Expense Q2 2023 · Jun 30, 2022 $2.67M
Sga Expense Q2 2023 · Jun 30, 2022 $6.96M
Rd Expense Q2 2023 · Jun 30, 2023 $1.99M
Rd Expense Q2 2023 · Jun 30, 2023 $3.6M
Rd Expense Q2 2023 · Jun 30, 2022 $649.47K
Rd Expense Q2 2023 · Jun 30, 2022 $1.02M
Net Income Q2 2023 · Jun 30, 2023 −$2.62M
Net Income Q2 2023 · Jun 30, 2023 −$5.07M
Net Income Q2 2023 · Jun 30, 2022 −$3.32M
Net Income Q2 2023 · Jun 30, 2022 −$7.98M
Capex Q2 2023 · Jun 30, 2022 $1.55K